Adaptyv Bio shares results from its latest AI-driven protein design contest

Adaptyv Bio, a biotech firm focused on protein engineering, released the outcomes of its newest competition that tests how well artificial‑intelligence models can create novel proteins.

The challenge, now in its third year, invited researchers worldwide to submit designs using current AI tools. Results were presented on Monday at the International Conference on Learning Representations (ICLR) in Rio de Janeiro.

According to the organizers, the latest entries demonstrate measurable improvements over earlier rounds, highlighting the growing capability of AI in tackling complex protein‑design problems. No specific drug candidates or commercial deals were announced as part of the competition.